Recent Company News

• 10:01 AM ET Aug 15, 2025
  

  JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025

• 05:10 PM ET Aug 13, 2025
  

  Akari Therapeutics reports Q2 EPS $0.00 vs year-ago $0.00 - 10-Q ($0.98, 0.00)

• 05:22 PM ET Jul 29, 2025
  

  Akari Therapeutics files $75M mixed shelf - S-3 ($1.08, 0.00)

• 08:41 AM ET Jul 22, 2025
  

  JTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live

• 08:54 AM ET Jul 18, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 07:27 AM ET Jul 18, 2025
  

  Akari Therapeutics initiated buy at Maxim Group ($1.13, 0.00)

• 08:53 AM ET Jun 18, 2025
  

  Akari Therapeutics announces patent issued for novel antibody drug conjugate immuno-oncology payload, PH1, in India ($1.18, 0.00)

• 04:53 PM ET May 14, 2025
  

  Akari Therapeutics reports Q1 GAAP EPS $0.00 vs year-ago $0.00 - 10-Q ($1.35, 0.00)

• 04:36 PM ET Apr 15, 2025
  

  Akari Therapeutics reports FY EPS $0.00 vs year-ago $0.00 - 10-K ($1.20, 0.00)

• 08:40 AM ET Mar 20, 2025
  

  Akari Therapeutics appoints Abizer Gaslightwala as President and CEO, effective 21-Apr ($1.25, 0.00)